These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 15635975)

  • 1. Parvovirus B19 viraemia in Dutch blood donors.
    Zaaijer HL; Koppelman MH; Farrington CP
    Epidemiol Infect; 2004 Dec; 132(6):1161-6. PubMed ID: 15635975
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epidemiology of high-level parvovirus B19 viraemia among Dutch blood donors, 2003-2009.
    Kooistra K; Mesman HJ; de Waal M; Koppelman MH; Zaaijer HL
    Vox Sang; 2011 Apr; 100(3):261-6. PubMed ID: 20946549
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevalence of human parvovirus B19 in blood donors as determined by a haemagglutination assay and verified by the polymerase chain reaction.
    Hitzler WE; Runkel S
    Vox Sang; 2002 Jan; 82(1):18-23. PubMed ID: 11856463
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Seroprevalence, molecular epidemiology and quantitation of parvovirus B19 DNA levels in Iranian blood donors.
    Zadsar M; Aghakhani A; Banifazl M; Kazemimanesh M; Tabatabaei Yazdi SM; Mamishi S; Bavand A; Sadat Larijani M; Ramezani A
    J Med Virol; 2018 Aug; 90(8):1318-1322. PubMed ID: 29663448
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Parvovirus B19 in South African blood donors.
    Francois KL; Parboosing R; Moodley P
    J Med Virol; 2019 Jul; 91(7):1217-1223. PubMed ID: 30840773
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Persistence of Parvovirus B19 (B19V) DNA and humoral immune response in B19V-infected blood donors.
    Juhl D; Görg S; Hennig H
    Vox Sang; 2014 Oct; 107(3):226-32. PubMed ID: 24916600
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lower Incidence of Parvovirus-B19 Infections in Dutch Blood Donors during SARS-CoV-2 Pandemic.
    Molenaar-de Backer MW; Hogema BM; Koppelman MH; van de Laar TJ; Slot E; Zaaijer HL
    Microbiol Spectr; 2021 Oct; 9(2):e0025321. PubMed ID: 34523999
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Presence and significance of parvovirus B19 in blood and blood products.
    Siegl G; Cassinotti P
    Biologicals; 1998 Jun; 26(2):89-94. PubMed ID: 9811511
    [No Abstract]   [Full Text] [Related]  

  • 9. Seroprevalence of parvovirus B19 infection in daycare educators.
    Gilbert NL; Gyorkos TW; Béliveau C; Rahme E; Muecke C; Soto JC
    Epidemiol Infect; 2005 Apr; 133(2):299-304. PubMed ID: 15816155
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of transfusion on human erythrovirus B19-susceptible or -infected pediatric recipients in a genotype 3-endemic area.
    Parsyan A; Addo-Yobo E; Owusu-Ofori S; Akpene H; Sarkodie F; Allain JP
    Transfusion; 2006 Sep; 46(9):1593-600. PubMed ID: 16965589
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Detection frequencies and viral load distribution of parvovirus B19 DNA in blood and plasma donations in England.
    Williams S; Ratcliff J; Nguyen D; Simmonds P; Harvala H;
    Transfus Med; 2022 Oct; 32(5):402-409. PubMed ID: 35751630
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High prevalence of parvovirus B19 IgG antibodies among Dutch hemophilia patients.
    Mauser-Bunschoten EP; Zaaijer HL; van Drimmelen AA; de Vries S; Roosendaal G; van den Berg HM; Lelie PN
    Vox Sang; 1998; 74(4):225-7. PubMed ID: 9691402
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevalence of Parvovirus B19 Viremia Among German Blood Donations and the Relationship to ABO and Rhesus Blood Group Antigens.
    Healy K; Aulin LBS; Freij U; Ellerstad M; Brückle L; Hillmering H; Svae TE; Broliden K; Gustafsson R
    J Infect Dis; 2023 May; 227(10):1214-1218. PubMed ID: 36408632
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular and phylogenetic analyses of human Parvovirus B19 isolated from Brazilian patients with sickle cell disease and β-thalassemia major and healthy blood donors.
    Slavov SN; Haddad SK; Silva-Pinto AC; Amarilla AA; Alfonso HL; Aquino VH; Covas DT
    J Med Virol; 2012 Oct; 84(10):1652-65. PubMed ID: 22930515
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evidence for persistence of human parvovirus B19 DNA in bone marrow.
    Cassinotti P; Burtonboy G; Fopp M; Siegl G
    J Med Virol; 1997 Nov; 53(3):229-32. PubMed ID: 9365887
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Prevalence of Parvovirus B19 Infection in Chinese Xiamen Area Blood Donors].
    Ou SH; Xie JZ; Zhang YL; Ni HY; Song XY
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2016 Oct; 24(5):1572-1576. PubMed ID: 27784395
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevalence and quantitation of parvovirus B19 DNA levels in blood donors with a sensitive polymerase chain reaction screening assay.
    Kleinman SH; Glynn SA; Lee TH; Tobler L; Montalvo L; Todd D; Kiss JE; Shyamala V; Busch MP;
    Transfusion; 2007 Oct; 47(10):1756-64. PubMed ID: 17880600
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Safety of blood products and B19 parvovirus].
    Lefrère JJ; Maniez-Montreuil M; Morel P; Defer C; Laperche S
    Transfus Clin Biol; 2006 Oct; 13(4):235-41. PubMed ID: 16822687
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Results of a study of parvovirus B19 (Parvoviridae, Parvovirinae, Erythroparvovirus, Primate erythroparvovirus 1) prevalence and circulation activity in socially significant categories of the population].
    Nikishov ON; Kuzin AA; Zobov AE; Lavrentieva IN; Antipova AY; Ostankova YV; Khamitova IV; Nikishov SN
    Vopr Virusol; 2020 Jul; 65(3):143-149. PubMed ID: 33533216
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antiphospholipid antibodies in pediatric and adult patients with rheumatic disease are associated with parvovirus B19 infection.
    Von Landenberg P; Lehmann HW; Knöll A; Dorsch S; Modrow S
    Arthritis Rheum; 2003 Jul; 48(7):1939-47. PubMed ID: 12847688
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.